The authors use new data from the 2021 Hospital Price Transparency initiative to determine that the market-leading insurer in the least competitive (most concentrated) insurance markets pays 15
percent less to hospitals than the market-leading insurer in the most competitive (least concentrated) markets.
LoSasso and colleagues discuss the possibility that price transparency itself could change negotiations between insurers and hospitals.
Today in Forefront, Robert Phillips and Rebecca Etz discuss how proposed quality measures from the
Centers for Medicare and Medicaid Services (CMS) fall largely on primary care to collect and improve, and do not align with the high-value functions of primary care.
Nathaniel Tran and coauthors argue that Tennessee's rejection of federal HIV prevention funds threatens community prevention efforts,
and could cost more than $270 million in US taxpayer dollars to cover lifelong HIV treatment for preventable infections.
Health Affairs is launching a contest! The premise is simple. Finish the statement "You’re A Health Policy Wonk If…"
We'll share some of the submissions on Forefront in July, and the first-place winner of the contest will receive a Health Affairs tumbler and a free Unlimited membership for a year. Submit by May 31.
The 340B Drug Pricing Program offers eligible hospitals substantial discounts on drug purchases. Learn more about the 340B Drug Pricing Program and how it affects biosimilar uptake on an episode of our podcast, A Health Podyssey.
Health Affairs is the leading peer-reviewedjournalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking
content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
